Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Compounding Pharmacy Market 2018, Forecast to 2023
The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs.
Scope of the Report:
This report focuses on the Compounding Pharmacy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Compounding Pharmacy includes Pharmaceutical ingredient alteration (PIA), Pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), Pharmaceutical dosage alteration (PDA) and Specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2016 is about 33%.
Compounding Pharmacy is widely used in Consumers aged 18 and younger, Consumers aged 19 to 44, Consumers aged 45 to 64, Consumers aged 65 and older. The most proportion of Compounding Pharmacy is Consumers aged 45 to 64, and the proportion in 2016 is 40%. The trend of dental clinic is increasing.
Market competition is not intense Fagron, Wedgewood Pharma, CAPS, Fresenius Kabi, PharMEDium Servicesare the leaders of the industry, with high-end customers in the industry.
The worldwide market for Compounding Pharmacy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Institutional Pharmacy Solutions
Village Compounding Pharmacy
Triangle Compounding Pharmacy
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pharmaceutical ingredient alteration (PIA)
Pharmaceutical application alteration (PAA)
Currently unavailable pharmaceutical manufacturing (CUPM)
Pharmaceutical dosage alteration (PDA)
Specialized animal pharmaceutical manufacturing (SAPM)
Market Segment by Applications, can be divided into
Consumers aged 18 and younger
Consumers aged 19 to 44
Consumers aged 45 to 64
Consumers aged 65 and older
There are 15 Chapters to deeply display the global Compounding Pharmacy market.
Chapter 1, to describe Compounding Pharmacy Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Compounding Pharmacy, with sales, revenue, and price of Compounding Pharmacy, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Compounding Pharmacy, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Compounding Pharmacy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Compounding Pharmacy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source